1994 was a good year for agriculture and forestry. Production and value added emerged from the low of the preceding years. Incomes from agriculture were also on the rise. All important agricultural regions benefited from the strong recovery, but those concentrating on crop production and...

Objective: To estimate the 3-year incremental cost effectiveness and cost utility of introducing leflunomide into sequential therapy, consisting of the most frequently used disease-modifying antirheumatic drugs (DMARDs), for patients with rheumatoid arthritis in specialised, i.e....

Objective: To quantify direct costs of medication and cost of illness (according to functional capacity) for patients with rheumatoid arthritis (RA) in Germany, allowing further use in a health economic evaluation of sequential therapy with disease-modifying antirheumatic drugs (DMARDs) in...